Another edition of PCI Days 2026 has come to a close – the largest B2B trade fair for the pharmaceutical, cosmetics, and dietary supplements sectors in Central and Eastern Europe.
AJ LAW Uchańska Diskau was represented by Dr. Joanna Uchańska, who delivered a presentation on AI Compliance in the Dietary Supplements Industry. She shared not only her professional experience but also practical insights into the current challenges facing the food and dietary supplements market.
In the latest issue of “Świat Przemysłu Farmaceutycznego,” an article by attorney-at-law Joanna Uchańska, partner at AJ LAW Uchańska Diskau, entitled “Rap, Prescriptions and Legal Provisions: Can Literary Interpretation Defend Itself Before the Chief Pharmaceutical Inspector and What Does It Have to Do with Pharmaceutical Advertising?” has been published. The article is devoted to one of the most widely discussed decisions of the Chief Pharmaceutical Inspector in recent months and its potential consequences for the pharmaceutical market and contemporary marketing communication.
The week began on an intensive note for our law firm's team. As part of ongoing litigation matters, Joanna Uchańska, Attorney-at-Law and Partner at AJ LAW Uchańska Diskau, and Edyta Oleszczuk-Romańska, Attorney-at-Law at our firm, represented clients during hearings before administrative courts concerning issues in the field of food law, including food for special medical purposes (FSMPs).
On 9 June 2026, the conference of the National Council of Supplements and Nutrition (KRSiO) and the KRSiO General Assembly of Members took place. Among the participants was Dr. Joanna Uchańska, Partner at AJ LAW Uchańska Diskau and Vice-Chair of KRSiO. The event was held in Warsaw and brought together experts from the pharmaceutical industry and the dietary supplements sector.
We are pleased to announce that Dr. Joanna Uchańska, Partner at AJ LAW Uchańska Diskau, will be speaking at PCI Days 2026 – the largest B2B trade fair for the pharmaceutical, cosmetics, and dietary supplements industries in Central and Eastern Europe.
The dynamic development of digital media and the migration of a significant portion of social life into the online sphere have fundamentally transformed the way we perceive a person’s image. Today, image is an exceptionally broad concept—it is no longer merely a visual representation but has become an autonomous form of expression, a tool for building identity, and the foundation of our digital presence. The internet now offers unprecedented opportunities for developing creativity, sharing passions, and shaping one’s own voice in the public sphere. Active participation in this world enables the natural acquisition of key digital, social, and communication skills. On the other hand, this dynamic reality brings with it serious legislative challenges and threats, such as deepnude technology, identity theft, and cyber-kidnapping.
The latest May issue of "Food Industry" (Przemysł Spożywczy) features an article by Aleksandra Diskau, Esq., a partner at the AJ LAW Uchańska Diskau law firm, titled "Chemical Safety of Food – Legal and Analytical Aspects of Pesticide Control in the Era of Cumulative Risk Assessment," dedicated to current challenges related to the control of plant protection product residues in food and dietary supplements.
On May 27, 2026, a meeting of the Parliamentary Committee for Pro-Health Food and Nutrition took place in the Sejm of the Republic of Poland – an important forum dedicated to the future of the dietary supplement market, food safety, and directions for the development of innovation in the health & wellness industry.
The relationship between freedom of artistic expression and the restrictive provisions of pharmaceutical law has become the subject of an unprecedented ruling by supervisory authorities. In a decision dated April 2, 2026 (reference number: POWII.600.8.2026.JD.6), the Chief Pharmaceutical Inspector (GIF) assessed the work of one of the most popular Polish musical artists, concluding that the content contained therein goes beyond the framework of artistic expression and constitutes prohibited advertising of medicinal products.
For businesses operating in the trade and distribution sector, payment backlogs represent one of the key operational risks. The President of the Office of Competition and Consumer Protection (UOKiK) is systematically tightening supervision over the timeliness of B2B settlements. Ignoring warning signals from the authority may result in the initiation of formal administrative proceedings, which typically conclude with the imposition of substantial mandatory financial penalties.
